The Individual Therapy for Patients With Wilson's Disease

• Status: Recruiting
• Trial end date: 2024-12-31
• Target enrollment: 0
• Participant gender: All

Summary

Based on the genotype characteristics and genotype-phenotype-treatment prognosis data of Chinese WD patients, this study intends to further optimize the treatment regimen of Chinese WD patients and formulate individualized treatment regimens for each genotype, so as to further improve the prognosis of patients.

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
• Treatments: Penicillamine; Succimer; Zinc

Criteria

Inclusion Criteria:

• Genetic diagnosis of Wilson's disease

• Presymptomatic patients with Wilson's disease

Exclusion Criteria:

• Movement disorder due to other definite causes instead of Wilson's disease

• Severe Lung, kidney or liver disease

• Neoplastic Disease